Podcast
Practical AI in Healthcare
Hosted by Steven Labkoff, MD and Leon Rozenblit, JD, PhD · EN
AI promises to transform healthcare—but real, scalable impact remains rare. Practical AI in Healthcare cuts through the noise to showcase real-world use cases delivering business value today. Hosted by senior leaders— former VPs of life science technology groups, clinical informatics professionals from top-tier organizations, and a former Big Four consultant—each episode features candid conversations with the people making AI work inside the healthcare enterprise
36episodes
Episodes
Newest firstAll episodes
S1, E41 - Hugo Campos: Patient-Directed AI
5d ago00:51:37Summary readyPatient advocate Hugo Campos spent more than a decade fighting for access to the data from his own implanted defibrillator. When the system wouldn't budge, he stopped trying to reform it and started building around it. In this episode, Hugo shows how he used agentic AI coding tools to create OpenKP, an open-source app that liberates his records from inside Kaiser Permanente, despite calling himself a non-coder. He and the hosts unpack the line between institutional AI and patient-directed AI, the discipline of having two AIs check each other, and why he believes "critical AI health literacy" now matters more than knowing how to code.https://practicalaiinhealthcare.com/
SummaryS1, E40 - Jeff Smith — AI Regulation, Transparency & Innovation from the Government Perspective
2w ago00:43:40Summary readyWhat happens when the rules for getting AI into clinical care are written by someone who has spent his career inside both the advocacy world and the government? In this episode, we talk with Jeff Smith of ONC at HHS, the first government official on Practical AI in Healthcare. Smith walks us through ONC's proposed HTI-5 rule, including a striking move to treat AI agents as "users" with the same data-access rights as clinicians, and a new question about whether blocking data from being written back into the EHR is itself information blocking. We also dig into the limits of what a regulator can actually do, and why the real work is coordination across agencies rather than control from any one of them.https://practicalaiinhealthcare.com/https://www.youtube.com/@PracticalAIinHealthcare
SummaryS1, E39 - Sarah Rossetti, RN, PhD: Nursing Informatics & the CONCERN Early Warning System
3w ago00:53:05Summary readyOn National Nurses Day, Practical AI in Healthcare welcomes its first nurse: Sarah Rossetti, RN, PhD, of Columbia University. Her CONCERN early warning system takes an unusual approach to predicting patient deterioration. Instead of modeling a patient's vital signs and labs, it models the nurse's documentation behavior, since the frequency and timing of charting reflect clinical concern long before the numbers move. In a 74-unit randomized trial of more than 60,000 patients, published in Nature Medicine, CONCERN was associated with a 35.6% reduction in instantaneous mortality risk. Rossetti and the hosts unpack the method, the counterintuitive rise in ICU transfers, equity safeguards, and what ambient AI means for the signal.https://practicalaiinhealthcare.com/episodes/#S1E39More on Sarah Rossetti's work: https://www.dbmi.columbia.edu/profile/sarah-collins-rossetti/
SummaryS1, E38 - Reflections 5: How Specialized Does AI Have to Be to Actually Work?
4w ago00:34:55Summary readyIn their fifth Reflections episode, Steve and Leon look back across six conversations (Matt Truppo at Sanofi, Ted Shortliffe, Barry Chaiken, David Hidalgo-Gato, and Danny van Leeuwen) to ask a sharper question: how specialized does AI have to be to actually work? The throughline is depth. The LLM is a commodity, and so, increasingly, is the generalist agent. What stays scarce is specialization in a workflow, the revival of symbolic methods like knowledge graphs, the literacy that separates an AI's ~95% solo accuracy from the under-35% people get using it themselves, and leaders willing to use themselves as the test rig. After 37 episodes, the technology is no longer the question. The specificity of the work around it is.
SummaryS1, E37 - Danny van Leeuwen, MPH, RN, Health Hats: Patient's POV on AI Tools
May 1700:42:22Summary readyDanny van Leeuwen is a nurse of 50 years, a multiple sclerosis patient, host of the Health Hats podcast, and a serial member of national outcomes panels at CMS, AHRQ, PCORI, and the National Academy of Medicine. He has tried more than 100 health apps and uses five. In this episode, he explains how he uses AI to interrogate his own chart, surface symptom patterns, and prepare for clinical encounters, and he shares his Three T's and Two C's framework for evaluating any digital health technology: Time, Trust, Talk, Control, Connection. The conversation covers what patients want from AI, what they do not, and why pain, fear, and cognition still escape the data.
SummaryS1, E36 - David Hidalgo-Gato, Founder & CEO, Cleo Health: Going a Mile Deep on Emergency Medicine — Specialization, Design Partnerships, and the Acute Care OS
May 1000:49:33Summary readyDavid Hidalgo-Gato is the founder and CEO of Cleo Health. While more than 100 competitors were building generic ambient AI scribes, David's team chose emergency medicine and stayed with one design partner for nine months and roughly 50 product iterations before launching. The result: an average 54-minute time savings per shift, a patient-assignment tool that turned a four-hour process into 15 to 20 minutes, and use across 400+ hospitals nationwide. The conversation covers why ED workflow breaks generic ambient scribes, why generative AI fits patient assignment specifically, and David's argument that workflow understanding is the moat AI cannot commoditize.https://practicalaiinhealthcare.com/
SummaryS1, E35 - Barry P. Chaiken, MD, MPH: Physician-as-Patient Perspective on AI in Healthcare
May 300:53:30Summary readyWhen physician Barry Chaiken was diagnosed with prostate cancer, his clinical training gave way to fear. It took a friend asking, "What are you doing?" to snap him back into doctor-mode thinking. That experience reshaped how he sees AI in healthcare. In this episode, Chaiken draws on his dual perspective as physician and two-time cancer survivor to argue that consumer health AI is failing patients, not because the models are bad, but because patients don't know how to use them. He shares a practical framework for AI-assisted patient education, makes the case for an aviation-style safety reporting system for healthcare AI, and explains why interoperability is an incentive problem, not a technology problem.
SummaryS1, E34 - Matt Truppo, PhD, Part 2: AI-Driven Drug Development at Sanofi: Clinical Trials, Regulatory, and Personal AI
Apr 2600:56:47Summary readyIn Part 2 of our conversation with Matt Truppo, Global Head of Research Platforms and Computational R&D at Sanofi, we move from discovery to development, where the real stakes begin. Matt unpacks the promise and limitations of “digital patient twins,” a concept often described as the holy grail of drug development. With nearly 90% of drugs failing in clinical trials, even modest gains in predicting efficacy or patient response could transform the industry. Through real-world examples, including Dupixent and rare disease therapies, Matt shows how quantitative systems pharmacology (QSP) and AI-driven simulations are already shortening timelines, reducing patient burden, and, in some cases, eliminating the need for entire trials.But the story doesn’t stop at modeling. We explore how AI is reshaping clinical operations, from Sanofi’s “clinical control tower” that integrates trial data across 4,000 users, to generative AI tools that are cutting regulatory document creation time by more than a third. Matt also shares a personal experiment, building a network of AI agents modeled on his own workflow, reclaiming 30% of his time and offering a glimpse into a more “agentic” future of work. The throughline is clear: AI is not replacing human expertise, but amplifying it, helping the industry finally bend the cost and time curve of drug development.
SummaryS1, E33 - Ted Shortliffe, MD, PhD: 50 Years of Clinical AI
Apr 1900:48:25Summary readyTed Shortliffe built MYCIN at Stanford in the 1970s, one of the first medical AI systems ever deployed in a clinical setting. Five decades later, he joins Steve and Leon to examine what has persisted in clinical decision support — above all, the demand for explainability — what has changed (computational power finally caught up to the ideas), and what the field may have lost along the way. The conversation includes a direct response to Bob Wachter's claim from S1E24 that AI in healthcare decision support was "too hard a problem to start with," and a case for why structured knowledge representation deserves a second look in the age of LLMs. For anyone tracing the arc of medical AI history, this episode is a rare primary source.
SummaryS1, E32 - Matt Truppo, PhD: AI-Driven Drug Discovery at Sanofi
Apr 1200:52:33Summary readyAI in drug discovery has been long on promise and short on delivery. Matt Truppo, Global Head of Research Platforms and Computational R&D at Sanofi, presents a different picture. His team used AI to identify 10+ novel drug targets in 12 months, screen 30 million target combinations in days, and produce AI-designed compounds with 75% synthesizability. But Truppo is equally candid about the gaps: data integration, explainability, and change management remain real barriers. In Part 1 of this two-part conversation, hosts Steve Labkoff and Leon Rozenblit explore what happens when AI moves past pilot projects into core pharmaceutical science.
Summary